Latest News in the pharma Industry

All

A new lipid technology for antiseptic emollient products

A new lipid technology for antiseptic emollient products

25 Apr 2017

Formulations can be delivered as spray, drop, solution, medical wipe or dermal patch.and offer non-touch applications.

Read more 
Novartis expands global collaboration with Amgen to commercialize first-in-class AMG 334 program in migraine prevention

Novartis expands global collaboration with Amgen to commercialize first-in-class AMG 334 program in migraine prevention

25 Apr 2017

Novartis and Amgen to co-commercialize AMG 334 (erenumab) in the US; Novartis to gain exclusive rights in Canada,

Read more 
Sartorius group invests $100 million in expansion of its plant in Yauco

Sartorius group invests $100 million in expansion of its plant in Yauco

25 Apr 2017

Is the largest single investment Sartorius Group has made outside Goettingen in the current year.

Read more 
Allergan granted marketing authorization by FDA for TrueTear

Allergan granted marketing authorization by FDA for TrueTear

25 Apr 2017

The first intranasal neurostimulating device proven to temporarily increase tear production.

Read more 
Web monitoring for capturing real-world feedback on drugs

Web monitoring for capturing real-world feedback on drugs

24 Apr 2017

First live demo of PLG’s powerful new AI-based social media listening solution, PLG inVolv, designed to help life sciences firms meet their pharmacovigilance obligations.

Read more 
Sanner passes 60 million euro mark

Sanner passes 60 million euro mark

24 Apr 2017

Significant investments in Bensheim headquarters; consistent portfolio additions; cleanroom expansion in China.

Read more 
Recipharm opens new GMP suite for clinical trial material

Recipharm opens new GMP suite for clinical trial material

24 Apr 2017

The $750k investment is intended to produce CTM for clinical studies up to Phase II for non-sterile dosage forms, including metered dose inhalers and semi-solid topical products.

Read more 
Lilly's breast cancer study of abemaciclib demonstrated superior progression-free survival at interim analysis

Lilly's breast cancer study of abemaciclib demonstrated superior progression-free survival at interim analysis

24 Apr 2017

The Phase III study compared abemaciclib in combination with an aromatase inhibitor versus an aromatase inhibitor alone in patients with HR+, HER2- advanced breast cancer.

Read more 
Recipharm delivers first serialised batch to Saudi Arabia

Recipharm delivers first serialised batch to Saudi Arabia

23 Apr 2017

Company has invested €300,000 into the project, which is part of a wider €40 million investment into new serialisation technology and processes to comply with the European Falsified Medicines Directive.

Read more 
Sandoz proposed biosimilars rituximab and etanercept recommended for approval in Europe

Sandoz proposed biosimilars rituximab and etanercept recommended for approval in Europe

23 Apr 2017

Company receives positive CHMP opinions for biosimilars rituximab and etanercept to treat immunological diseases. Biosimilar rituximab also recommended to treat blood cancers.

Read more 
BMS-986036 shows consistent improvement in liver fat, liver injury and fibrosis in patients with NASH in Phase II trial

BMS-986036 shows consistent improvement in liver fat, liver injury and fibrosis in patients with NASH in Phase II trial

23 Apr 2017

Primary endpoint of significant reduction in liver fat achieved following 16 weeks of treatment with BMS-986036.

Read more 
Pfizer unveils ATLAS, an Interactive, website that provides global antibiotic resistance surveillance data across 60 countries

Pfizer unveils ATLAS, an Interactive, website that provides global antibiotic resistance surveillance data across 60 countries

23 Apr 2017

Website can help inform global health strategies to mitigate the threat of antimicrobial resistance.

Read more